Patents by Inventor Jim Alexiou

Jim Alexiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DAPTOMYCIN FORMULATIONS AND USES THEREOF
    Publication number: 20200237858
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Application
    Filed: April 15, 2020
    Publication date: July 30, 2020
    Applicant: Hospira Australia Pty Ltd
    Inventors: Jim Alexiou, Andrew Malcolm Knill, Noel Norris, Darryl Whittaker
  • Daptomycin formulations and uses thereof
    Patent number: 10357535
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: July 23, 2019
    Assignee: Hospira Australia Pty Ltd
    Inventors: Jim Alexiou, Andrew Malcolm Knill, Noel Norris, Darryl Whittaker
  • DAPTOMYCIN FORMULATIONS AND USES THEREOF
    Publication number: 20180177843
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Applicant: HOSPIRA AUSTRALIA PTY LTD
    Inventors: Jim Alexiou, Andrew Malcolm Knill, Noel Norris, Darryl Whittaker
  • DAPTOMYCIN FORMULATIONS AND USES THEREOF
    Publication number: 20170216396
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Application
    Filed: April 20, 2017
    Publication date: August 3, 2017
    Applicant: HOSPIRA AUSTRALIA PTY LTD.
    Inventors: Jim Alexiou, Andrew Malcolm Knill, Noel Norris, Darryl Whittaker
  • Daptomycin formulations and uses thereof
    Patent number: 9655946
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: May 23, 2017
    Assignee: HOSPIRA AUSTRALIA PTY LTD.
    Inventors: Jim Alexiou, Andrew Knill, Noel Norris, Darryl Whittaker
  • DAPTOMYCIN FORMULATIONS AND USES THEREOF
    Publication number: 20150313958
    Abstract: Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.
    Type: Application
    Filed: September 11, 2013
    Publication date: November 5, 2015
    Applicant: HOSPIRA AUSTRALIA PTY LTD.
    Inventors: Jim Alexiou, Andrew Knill, Noel Norris, Darryl Whittaker